Medi Lifestyle (SGX:Z4D) EBITDA Margin %: -265.43% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Medi Lifestyle EBITDA Margin %?

Medi Lifestyle SGX:Z4D EBITDA Margin % is -265.43% as of Mar. 2026. The stock has 5 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Medi Lifestyle ranks worse than 94.88% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Medi Lifestyle's EBITDA for the three months ended in Mar. 2026 was S$-0.22 Mil. Medi Lifestyle's Revenue for the three months ended in Mar. 2026 was S$0.08 Mil. Therefore, Medi Lifestyle's EBITDA margin for the quarter that ended in Mar. 2026 was -265.43%.


Medi Lifestyle  (SGX:Z4D) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Medi Lifestyle EBITDA Margin % Related Terms


Medi Lifestyle EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Medi Lifestyle's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medi Lifestyle EBITDA Margin % Chart

Medi Lifestyle Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -655.53 -145.52 -317.99 -254.48 -83.94

Medi Lifestyle Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.20 -113.33 -845.95 -451.43 -265.43

SGX:Z4D vs HCA, THC, DVA: EBITDA Margin % Comparison

For the Medical Care Facilities subindustry, Medi Lifestyle's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medi Lifestyle EBITDA Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medi Lifestyle's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Medi Lifestyle's EBITDA Margin % falls into.



Medi Lifestyle EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Medi Lifestyle's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-1.171/1.395
=-83.94 %

Medi Lifestyle's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.215/0.081
=-265.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -265.43% mean?
Medi Lifestyle (SGX:Z4D) has a EBITDA Margin % of -265.43% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Medi Lifestyle and its competitors. According to the industry distribution chart, Medi Lifestyle ranks #630 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 94.9%.
Is Medi Lifestyle's EBITDA Margin % too high?
Medi Lifestyle's current EBITDA Margin % is -265.43%. Based on the distribution chart, Medi Lifestyle ranks #630 out of 664 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Medi Lifestyle's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medi Lifestyle ranks #630 out of 664 companies for EBITDA Margin %. This places Medi Lifestyle in the lower half of its industry. The industry median EBITDA Margin % is 10.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Medi Lifestyle and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medi Lifestyle's current EBITDA Margin % is -265.43%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medi Lifestyle stock overvalued right now?
Medi Lifestyle (SGX:Z4D) has a current EBITDA Margin % of -265.43%. The current EBITDA Margin % is -265.43%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Medi Lifestyle (SGX:Z4D), the current EBITDA Margin % is -265.43% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medi Lifestyle Business Description

Address 72A Jalan Prof Diraja, 100.03.015, Level 3, Block J, Ungku Aziz, Seksyen 13, Petaling Jaya, SGR, MYS, 46200
Medi Lifestyle Ltd is engaged in healthcare services within Asia, starting with postpartum care services. The company operates a chiropractic and physiotherapy centre (Back To Life) at Jaya One, Petaling Jaya. It also operates a business distributing cell-therapy products and cell-derived beauty solutions in Malaysia. The company operates into four segments: Healthcare, Outsourced Services, Commodity Trading and Corporate. Key revenue is generated from Outsourced Services. Geographically, It derived key revenue from China followed by Singapore and Malaysia.